Fu Shaoling, Yang Kai, Li Xueqian, Chen Cheng, Mei Guohua, Su Yan, Xue Jianfeng, Zou Jian, Zhang Jieyuan, Shi Zhongmin
Department of Orthopedic Surgery, Shanghai Sixth People's Hospital, Shanghai, China.
Department of Radiology, Shanghai Sixth People's Hospital, Shanghai, China.
Orthop J Sports Med. 2022 Oct 14;10(10):23259671221128772. doi: 10.1177/23259671221128772. eCollection 2022 Oct.
Arthroscopic microfracture for osteochondral lesion of the talus (OLT) has shown good functional outcomes in the short and long term.
To investigate 5-year radiographic and clinical outcomes after arthroscopic microfracture in treatment of OLT and the effectiveness of adjunct therapies including platelet-rich plasma (PRP) and hyaluronic acid (HA).
Cohort study; Level of evidence, 2.
We prospectively enrolled 432 patients who underwent arthroscopic microfracture for OLT from May 1, 2011, to May 31, 2015. Magnetic resonance imaging (MRI) and weightbearing radiographs were performed annually after the initial surgery. The MOCART (magnetic resonance observation of cartilage repair tissue) score was used to evaluate the structure of the repaired cartilage on MRI, and patient-reported outcomes (American Orthopaedic Foot and Ankle Society ankle-hindfoot scale [AOFAS] and the Foot and Ankle Outcome Score) were collected annually. The primary outcome measure was 5-year AOFAS score. We recorded baseline characteristics including age, body mass index (BMI), and lesion size, and other potentially related factors including number of PRP/HA injection and change in BMI from baseline.
Included were 355 patients, all with minimum 5-year follow-up data. The overall reoperation rate was 9.0% (32 of 355). According to multivariable analysis, 5-year AOFAS scores were associated with number of PRP injections (correlation coefficient, 3.12 [95% CI, 2.36 to 3.89]; < .001), BMI at baseline (correlation coefficient, -0.222 [95% CI, -0.363 to -0.082]; = .002), and mean BMI change from baseline (correlation coefficient, -1.15 [95% CI, -1.32 to -0.98]; < .001). When comparing number of PRP injections (0, 1-2, or ≥3), we found that patients who had serial PRP injection (≥3 with at least a 3-month interval between injections) had diminished functional and radiographic deterioration over time.
Arthroscopic microfracture improved patient-reported and structural outcomes for patients with OLT at 5 years after surgery. Serial PRP injections and reduction in BMI from baseline were able to slow radiographic and functional deterioration. Future trials regarding the combination of microfracture and PRP in treatment of OLT should focus on the efficacy of longer term, intra-articular, serial injections of PRP instead of single injections.
关节镜下微骨折术治疗距骨骨软骨损伤(OLT)在短期和长期均显示出良好的功能预后。
探讨关节镜下微骨折术治疗OLT的5年影像学和临床预后,以及包括富血小板血浆(PRP)和透明质酸(HA)在内的辅助治疗的有效性。
队列研究;证据等级,2级。
我们前瞻性纳入了2011年5月1日至2015年5月31日期间接受关节镜下微骨折术治疗OLT的432例患者。初次手术后每年进行磁共振成像(MRI)和负重X线片检查。采用MOCART(软骨修复组织磁共振观察)评分评估MRI上修复软骨的结构,并每年收集患者报告的预后指标(美国矫形足踝协会踝-后足评分[AOFAS]和足踝预后评分)。主要预后指标为5年AOFAS评分。我们记录了基线特征,包括年龄、体重指数(BMI)和损伤大小,以及其他潜在相关因素,包括PRP/HA注射次数和BMI相对于基线的变化。
纳入355例患者,均有至少5年的随访数据。总体再手术率为9.0%(355例中的32例)。根据多变量分析,5年AOFAS评分与PRP注射次数(相关系数,3.12[95%CI,2.36至3.89];P<0.001)、基线BMI(相关系数,-0.222[95%CI,-0.363至-0.082];P=0.002)以及BMI相对于基线的平均变化(相关系数,-1.15[95%CI,-1.32至-0.98];P<0.001)相关。比较PRP注射次数(0次、1 - 2次或≥3次)时,我们发现接受连续PRP注射(≥3次且每次注射间隔至少3个月)的患者随着时间推移功能和影像学恶化程度减轻。
关节镜下微骨折术改善了OLT患者术后5年的患者报告预后和结构预后。连续PRP注射以及BMI相对于基线的降低能够减缓影像学和功能恶化。未来关于微骨折术联合PRP治疗OLT的试验应关注长期关节内连续注射PRP而非单次注射的疗效。